Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: Improving in vivo ocular bioavailability

Journal of Pharmaceutical Sciences

Volumn 101, Issue 10, 2012, Pages 3833-3844

  Liu, Rui ^a   Liu, Zhidong ^a   Zhang, Chengui ^b   Zhang, Boli ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Tianjin Lerentang Pharmaceutical Factory   (China)

Author keywords

Absorption enhancer; Bioavailability; Lipids; Mangiferin; Microdialysis; Nanoparticles; Nanostructured lipid carriers (NLCs); Ocular delivery; Pharmacokinetics; Physical characterization

Indexed keywords

DRUG CARRIER; LIPID; MANGIFERIN; NANOMATERIAL;

AQUEOUS HUMOR; ARTICLE; BIOAVAILABILITY; CATARACT; CONTROLLED STUDY; CORNEA PERMEABILITY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG RETENTION; HISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; MICRODIALYSIS; MICROSCOPY; MORPHOLOGY; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PROCESS OPTIMIZATION; SLIT LAMP; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 84865355409     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23251     Document Type: Article

References (35)

1. Nanjawade BK, Manvi FV, Manjappa AS. 2007. In situ-forming hydrogels for sustained ophthalmic drug delivery. J Control Release 122:119-134.
2. Gonzalez-Mira E, Egea MA, Garcia ML, Souto EB. 2010. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC. Colloids Surf B Biointerfaces 81:412-421.
3. Müller RH, Radtke M, Wissing SA. 2002. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 54:S131-S155.
4. Müller RH, Radtke M, Wissing SA. 2002. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 242:121-128.
5. Souto EB, Doktorovova S, Gonzalez-Mira E, Egea MA, Garcia ML. 2010. Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs. Curr Eye Res 35:537-552.
6. Souto EB, Müller RH. 2010. Lipid nanoparticles: Effect on bioavailability and pharmacokinetic changes. Handb Exp Pharmacol 197: 115-141.
7. Beebe DC, Holekamp NM, Shui YB. 2010. Oxidative damage and the prevention of age-related cataracts. Ophthalmic Res 44:155-165.
8. Tharanathan RN, Yashoda HM, Prabha TN. 2006. Mango (Mangifera indica L.), "The king of fruits"-An overview. Food Rev Int 22:95-123.
9. Engels C, Knödler M, Zhao YY, Carle R, Gänzle MG, Schieber A. 2009. Antimicrobial activity of gallotannins isolated from mango (Mangifera indica L.) kernels. J Agric Food Chem 57:7712-7718.
10. Sá-Nunes A, Rogerio AP, Medeiros AI, Fabris VE, Andreu GP, Rivera DG, Delgado R, Faccioli LH. 2006. Modulation of eosinophil generation and migration by Mangifera indica L. extract (Vimang®). Int Immunopharmacol 6:1515-1523.
11. Joubert E, Richards ES, Merwe JD, De Beer D, Manley M, Gelderblom WC. 2008. Effect of species variation and processing on phenolic composition and in vitro antioxidant activity of aqueous extracts of Cyclopia spp. (Honeybush Tea). J Agric Food Chem 56:954-963.
12. Li Y, Huang TH, Yamahara J. 2008. Salacia root, a unique Ayurvedic medicine, meets multiple targets in diabetes and obesity. Life Sci 82:1045-1049.
13. Puglia C, Sarpietro MG, Bonina F, Castelli F, Zammataro M, Chiechio S. 2011. Development, characterization, and in vitro and in vivo evaluation of benzocaine- and lidocaine-loaded nanostructrured lipid carriers. J Pharm Sci 100:1892-1899.
14. Vega E, Egea MA, Valls O, Espina M, Garcia ML. 2006. Flurbiprofen loaded biodegradable nanoparticles for ophthalmic administration. J Pharm Sci 95:2393-2405.
15. Gonzalez-Mira E, Egea MA, Souto EB, Calpena AC, García ML. 2011. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery. Nanotechnology 22:45-101.
16. Liu ZD, Zhang XH, Li JW, Liu R, Shu LX, Jin J. 2009. Effects of Labrasol on the corneal delivery of baicalin. Drug Deliv 16:399-404.
17. Lallemand F, Furrer P, Felt-Baeyens O, Gex-Fabry M, Dumont JM, Besseghir K, Gurny R. 2005. A novel water-soluble cyclosporine A prodrug: Ocular tolerance and in vivo kinetics. Int J Pharm 295:7-14.
18. Cavalli R, Gasco MR, Chetoni P, Burgalassi S, Saettone MF. 2002. Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Int J Pharm 238:241-245.
19. Rittenhouse KD, Pollack GM. 2000. Microdialysis and drug delivery to the eye. Adv Drug Deliv Rev 45:229-241.
20. Kohane DS, Tse JY, Yeo Y, Padera R, Shubina M, Langer R. 2006. Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum. J Biomed Mater Res Part A 77:351-361.
21. Patil MN, Gore GM, Pandit AB. 2008. Ultrasonically controlled particle size distribution of explosives: A safe method. Ultrason Sonochem 15:177-187.
22. González-Mira E, Nikolić S, García ML, Egea MA, Souto EB, Calpena AC. 2011. Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen. J Pharm Sci 100:241-251.
23. Das S, Suresh PK, Desmukh R. 2010. Design of Eudragit RL100 nanoparticles by nanoprecipitation method for ocular drug delivery. Nanomedicine 6:318-323.
24. Mehnert W, Mäder K. 2001. Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev 47:165-196.
25. Quintanar-Guerrero D, Tamayo-Esquivel D, Ganem-Quintanar A, Allémann E, Doelker E. 2005. Adaptation and optimization of the emulsification-diffusion technique to prepare lipidic nanospheres. Eur J Pharm Sci 26:211-218.
26. Venkateswarlu V, Manjunath K. 2004. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J Control Release 95:627-638.
27. Urbán-Morlán Z, Ganem-Rondero A, Melgoza-Contreras LM, Escobar-Chávez JJ, Nava-Arzaluz MG, Quintanar-Guerrero D. 2010. Preparation and characterization of solid lipid nanoparticles containing cyclosporine by the emulsification-diffusion method. Int J Nanomedicine 5:611-620.
28. Jiao J. 2008. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery. Adv Drug Deliv Rev 60:1663-1673.
29. Joshi MD, Müller RH. 2009. Lipid nanoparticles for parenteral delivery of actives. Eur J Pharm Biopharm 71:161-172.
30. Liu R, Liu ZD, Zhang CG, Zhang BL. 2011. Gelucire44/14 as a novel absorption enhancer for drugs with different hydrophilicities: In vitro and in vivo improvement on transcorneal permeation. J Pharm Sci 100:3186-3195.
31. Liu R, Liu ZD, Shu LX, Zhang CG, Zhang BL. 2010. Effect of three penetration enhancers on corneal permeability of mangiferin in vitro. Chin J Chin Mater Med 35:3131-3135.
32. Ludwig A. 2005. The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev 57:1595-1639.
33. Katragadda S, Gunda S, Hariharan S, Mitra AK. 2008. Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: Evaluation of their utility in treating ocular HSV infections. Int J Pharm 359:15-24.
34. Sinha S, Ali M, Baboota S, Ahuja A, Kumar A, Ali J. 2010. Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir. AAPS Pharm Sci Tech 11:518-527.
35. Müller-Goymann CC. 2004. Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration. Eur J Pharm Biopharm 58:343-356.